[1]
Samura, B.B. 2018. Interactions between galectin-3 and cardiovascular risk in patients with chronic lymphocytic leukemia in remission: results of 3-year prospective study. Current issues in pharmacy and medicine: science and practice. 3 (Oct. 2018). DOI:https://doi.org/10.14739/2409-2932.2018.3.145251.